When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Nondiabetic hypoglycemia

Evidence last reviewed: 15 Aug 2026
Topic last updated: 02 Sep 2026

Summary

Definition

History and exam

Key diagnostic factors

  • diaphoresis
  • anxiety
  • tremor
  • hunger
  • generalized tingling
  • nausea
  • palpitations
  • confusion
  • irritability
  • blurred vision
  • drowsiness
Full details

Other diagnostic factors

  • unexplained weight gain
  • unexplained weight loss
  • hyperpigmentation
  • hypotension
  • short stature
Full details

Risk factors

  • middle age
  • ethanol consumption
  • bariatric surgery
  • liver failure
  • renal failure
  • intense exercise
  • fibromas
  • sarcomas
  • fibrosarcomas
  • insulinoma
  • adrenal insufficiency
  • growth hormone deficiency
  • hypopituitarism
  • sepsis
  • glycogen storage diseases
  • anorexia nervosa
  • malnutrition
  • exogenous insulin
  • ackee fruit ingestion
  • haloperidol exposure
  • quinine exposure
  • fluoroquinolone exposure
  • sulfonylurea or meglitinide exposure
  • disopyramide exposure
  • beta-blocker exposure
  • salicylate or nonsteroidal anti-inflammatory drug (NSAID) exposure
  • heparin exposure
  • tramadol exposure
  • proton-pump inhibitor (PPI) exposure
Full details

Diagnostic tests

1st tests to order

  • serum glucose
Full details

Tests to consider

  • liver function testing
  • renal function testing
  • serum insulin
  • serum C-peptide
  • serum beta-hydroxybutyrate (BHB)
  • serum insulin secretagogue level
  • thyroid-stimulating hormone levels
  • serum cortisol
  • 48-72 hour fast under supervision
  • serum insulin-like growth factor (IGF)-II
  • serum adrenocorticotropic hormone (ACTH)
  • serum human growth hormone (HGH)
  • serum proinsulin
  • CT scan abdomen and pelvis with and without intravenous contrast
  • transabdominal ultrasound
  • endoscopic ultrasound
  • MRI
Full details

Treatment algorithm

ACUTE

reactive hypoglycemia

exposure to drug, toxin, alcohol

bariatric surgery, anorexia, malnutrition, ackee fruit ingestion

insulinoma

IGF-II-secreting tumor

renal failure, liver failure, sepsis, or other endocrinopathy

Contributors

Authors

Udaya Kabadi, MD

Professor of Medicine

University of Iowa

Des Moines Internal Medicine Residency Training Program

Staff Endocrinologist

Veterans Affairs Medical Center

Des Moines, IA

Disclosures

UK is an author of a number of references cited in this topic.

Bilal H. Baig, DO

Adjunct Assistant Professor

Department of Internal Medicine

University of Iowa - Roy J. and Lucille A. Carver College of Medicine

Iowa City, IA

Disclosures

BB declares that he has no competing interests.

Acknowledgements

Professor Udaya Kabadi would like to gratefully acknowledge Dr Steven Kunkel, a previous contributor to this topic.

Disclosures

SK declares that he has no competing interests.

Peer reviewers

David J. Leehey, MD

Section Chief

Renal and Hypertension

Professor of Medicine

Division of Nephrology

Department of Medicine

Loyola University School of Medicine and Edward Hines Jr VA Medical Center

Hines, IL

Disclosures

DJL declares that he has no competing interests.

Shehzad Basaria, MD

Assistant Professor

Johns Hopkins University School of Medicine

Baltimore, MD

Disclosures

SB declares that he has no competing interests.

David Hopkins, FRCP

Clinical Director/Clinical Lead for Diabetic Medicine

King’s College Hospital NHS Foundation Trust

London

Disclosures

DH declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Kandaswamy L, Raghavan R, Pappachan JM. Spontaneous hypoglycemia: diagnostic evaluation and management. Endocrine. 2016 Jul;53(1):47-57. Abstract

Hofland J, Falconi M, Christ E, et al. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol. 2023 Aug;35(8):e13318.Full text  Abstract

Kos-Kudła B, Castaño JP, Denecke T, et al. European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol. 2023 Dec;35(12):e13343.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Differentials

    • Idiopathic postprandial syndrome (pseudohypoglycemia)
    • Insulin autoimmune hypoglycemia
    • Diabetic hypoglycemia
    More Differentials
  • Guidelines

    • Society for Endocrinology guidelines for the diagnosis and management of post-bariatric hypoglycaemia
    • ENETS 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer